欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NL/H/4994/001
药品名称Bijuva 1mg/100mg zachte capsules
活性成分
    • Estradiol hemihydrate 1.0 mg
    • Progesterone 100.0 mg
剂型Capsule, soft
上市许可持有人Theramex Ireland Limited 3rd Floor, Kilmore House Spencer Dock, Park Lane Dublin 1, D01 YE64 Ireland
参考成员国 - 产品名称Netherlands (NL)
Bijuva 1mg/100mg zachte capsules
互认成员国 - 产品名称
    • Malta (MT)
      Bijuva Capsules, Soft 1mg/100mg
    • Germany (DE)
      Bijuva 1mg/ 100 mg Weichkapseln
    • Belgium (BE)
      Bijuva 1 mg/100 mg zachte capsules
    • Portugal (PT)
    • Luxembourg (LU)
    • United Kingdom (Northern Ireland) (XI)
    • France (FR)
    • Spain (ES)
    • Italy (IT)
    • Poland (PL)
      Bijuva
许可日期2021/02/25
最近更新日期2025/08/19
药物ATC编码
    • G03FA04 progesterone and estrogen
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Full Dossier Art 8.3(i) Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase